Compound index

Mitochondrial-Targeted Peptides

MOTS-c

Animal studiesNot approved for human use in the US

Last reviewed: 2026-11-19

Evidence status & limitations

Observational measurements of natural MOTS-c do not establish efficacy of external MOTS-c; clinical trials of modified analogs are not trials of this exact peptide.

Regulatory status

No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.

    Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

    WADA prohibited status: current list and context

    Known risks & open questions

    Reliable human intervention safety and long-term outcomes remain unestablished.

    Key sources

    Primary-reference and editorial check: November 19, 2026. Not an exhaustive clinical review; exact formulations and populations matter.

    Related compounds

    • Elamipretide

      Same scientific class · A 4-amino-acid chain. · FDA-approved for specific indications

    Related glossary terms